Arpa-H
Entity.
- Evidence
- 25 documents · 11 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 3 Sept 2026, last seen 6 Oct 2026
- Measured
- 36% of mentions say something specific about it; the rest only name it
- As of
- 8 Oct 2026
Where this comes from
- MIT Technology Review · 2026-10-06 · Weight-loss drugs show signs of slowing biological aging, say drugmakers (opens the source in a new tab)
- FDA · 2026-10-06 · FDA Seeks Public Input to Support Ibogaine Research (opens the source in a new tab)
- Chemical & Engineering News · 2026-10-03 · Policy Watch: SBA presses case on styrene, citing dichloromethane ruling (opens the source in a new tab)
- GEN · 2026-10-03 · FDA to Highlight Aging, Longevity Medicine in Planned FARS Updates (opens the source in a new tab)
- Pulse 2.0 · 2026-10-02 · University of Texas Joins ARPA-H Effort To Modernize Clinical Trials (opens the source in a new tab)
- STAT · 2026-09-30 · STAT+: Anthropic joins ARPA-H clinical AI moonshot, will hold closed-door health care event (opens the source in a new tab)
- SAM.gov · 2026-09-25 · ARPA-H Comprehensive Organ System Modeling in Outer Space (COSMOS) Innovative Solutions Opening (opens the source in a new tab)
- Psychedelic Alpha · 2026-09-18 · ‘Move Fast, with Precision’: Notes from ARPA-H’s Ibogaine Workshop (opens the source in a new tab)
- Fierce Biotech · 2026-09-17 · ARPA-H launches SPECTRA program, new autism research initiative (opens the source in a new tab)
- GEN · 2026-09-09 · RNAV8 Bio Joins ARPA-H Team to Pioneer Programmable RNA Medicines (opens the source in a new tab)
- STAT News · 2026-09-03 · STAT+: ARPA-H funds biotechs working on custom RNA therapies (opens the source in a new tab)
- Psychedelic Alpha · 2026-09-03 · Pα+ Psychedelic Bulletin #230: Pharma Ramps Up Ad Spend on Psychedelic Keywords; ARPA-H’s Ibogaine Funding; Psychedelics in Medicaid? (opens the source in a new tab)